Lexicon Pharmaceuticals, Inc. (LXRX) by event type
LXRX moves most on rating reiterations — a median of -0.24% at 30 minutes across 72 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the LXRX overview →
How LXRX reacts across 2 measured event types.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Coverage initiations 843 of 2,283 | 12 | +0.13% | 58% | -1.91% |
| Rating reiterations 3,026 of 3,522 | 72 | -0.24% | 44% | -0.29% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one. 4 further classes were observed with fewer than 10 measured events and are not published.
That’s how LXRX usually reacts — get an email when it moves on news →Every name measured for these event types: Coverage initiations → · Rating reiterations → · LXRX overview →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Cidara Therapeutics, Inc. (CDTX) | 339 | +0.06% | 52% |
| DaVita Inc. (DVA) | 339 | +0.07% | 53% |
| Cellect Biotechnology Ltd. - American Depositary Shares (APOP) | 337 | -0.42% | 35% |
| Cardinal Health, Inc. (CAH) | 335 | +0.02% | 52% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.